SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BONDANELLI, Marta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.729
EU - Europa 3.179
AS - Asia 1.589
SA - Sud America 26
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.527
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.696
DE - Germania 1.175
CN - Cina 917
UA - Ucraina 654
IT - Italia 497
SG - Singapore 333
TR - Turchia 284
GB - Regno Unito 200
RU - Federazione Russa 189
FI - Finlandia 141
PL - Polonia 116
SE - Svezia 108
FR - Francia 55
ID - Indonesia 32
MX - Messico 16
BR - Brasile 14
BE - Belgio 13
CA - Canada 13
IE - Irlanda 7
IN - India 7
CZ - Repubblica Ceca 6
EC - Ecuador 4
IR - Iran 4
JP - Giappone 4
RO - Romania 4
NL - Olanda 3
CL - Cile 2
DK - Danimarca 2
EU - Europa 2
GR - Grecia 2
NG - Nigeria 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
VE - Venezuela 2
VN - Vietnam 2
AR - Argentina 1
AT - Austria 1
BD - Bangladesh 1
BG - Bulgaria 1
BO - Bolivia 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
ES - Italia 1
HN - Honduras 1
KZ - Kazakistan 1
MC - Monaco 1
MD - Moldavia 1
MY - Malesia 1
PS - Palestinian Territory 1
PT - Portogallo 1
Totale 11.527
Salva come PNG Salva come JPEG
Città #
Woodbridge 905
Chandler 722
Jacksonville 675
Fairfield 604
Houston 394
Ashburn 391
Ann Arbor 342
Wilmington 276
Singapore 241
Seattle 211
Izmir 206
Addison 202
Nanjing 202
Beijing 192
Cambridge 183
Princeton 154
Warsaw 116
Milan 96
New York 93
San Diego 93
Shanghai 84
Shenyang 70
Boardman 66
Ferrara 58
Hebei 56
Dearborn 50
Los Angeles 48
Nanchang 46
Santa Clara 42
Bremen 39
Changsha 33
Jakarta 32
Tianjin 32
Jiaxing 30
Falls Church 25
Kunming 24
Redwood City 24
Jinan 23
Mountain View 23
Norwalk 21
Washington 20
Helsinki 18
Zhengzhou 17
Ningbo 15
Munich 14
San Mateo 14
Brussels 13
Guangzhou 13
London 13
Auburn Hills 12
Bologna 12
Hefei 11
Orange 11
Leawood 9
Rome 9
Taizhou 9
Des Moines 7
Monmouth Junction 7
Philadelphia 7
Tappahannock 7
Augusta 6
Castelnuovo Rangone 6
Changchun 6
Hangzhou 6
Indiana 6
Redmond 6
Bari 5
Dallas 5
Lanzhou 5
Toronto 5
Verona 5
Chicago 4
Mexico 4
Pisa 4
Quito 4
Salerno 4
Treviso 4
Andover 3
Ardabil 3
Brescia 3
Caiazzo 3
Cordovado 3
Haikou 3
Jinhua 3
Lusia 3
Montréal 3
Mumbai 3
Napoli 3
Porangatu 3
Rimini 3
Savigliano 3
Sirmione 3
Terni 3
Walnut 3
Amsterdam 2
Antwerp 2
Bollate 2
Brembate 2
Brno 2
Cairate 2
Totale 7.510
Salva come PNG Salva come JPEG
Nome #
Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds 238
Recettori della somatostatina e carcinoma midollare della tiroide: prospettive future. 155
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism 145
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 141
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion. 137
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression. 136
Predictors of Pituitary Dysfunction in Patients Surviving Ischemic Stroke 130
null 130
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 127
Cerebral aneurysm and acromegaly: a case report 122
Pituitary side effects of old and new drugs. 122
Role of the serotonergic system in the genesis of vasovagal syncope. 121
null 118
In vitro testing of new somatostatin analogs on pituitary tumor cells 117
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 116
null 114
L’iperplasia surrenale congenita e la pubertà precoce 114
null 113
null 111
Somatostatin receptor subtype 1 selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line. 111
Acromegaly is associated with increased cancer risk: a survey in Italy 111
Growth hormone excess promotes breast cancer chemoresistance 108
Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame 107
null 106
null 106
Recettori della Somatostatina e Carcinoma Midollare della Tiroide: prospettive future. 105
null 104
Evaluation of bone markers and structure in subclinical Cushing’s syndrome 103
An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro 102
Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines 102
null 101
Modulatory effect of the renin-angiotensin system on the plasma levels of calcitonin gene-related peptide in normal man 100
Thyroid papillary microcarcinoma: a descriptive and meta-analysis study 100
Le alterazioni pressorie nell'acromegalia: fattori umorali 99
Acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide 98
null 98
Efficacy and safety of the new 60 mg formulation of the long acting somatostatin analog lanreotide in the treatment of acromegaly. 97
Predictors of morbidity and mortality in acromegaly: An Italian survey 95
Diurnal rhythm of plasma catecholamines in acromegaly 93
Endogenous estrogen status significantly influences the nutrition-related alterations in Growth Hormone-Binding protein levles in healthy women 93
Blood GH-binding protein levels in premenopausal and postmenopausal women: role of body weight and estrogen levels 91
null 91
RISK FACTORS FOR DEVELOPING HYPOPITUITARISM AFTER STROKE 91
Cardiac and metabolic effects of chronic GH and IGF1 excess in young adults with pituitary gigantism 90
Prevalence of hypopituitarismin patients with cerebrovascular diseases 89
Antiproliferative effects of somatostatin analogs in pituitary adenomas 89
Primary empty sella: Why and when to investigate hypothalamic-pituitary function 89
Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone (GH)- releasing hormone function 89
Prevalence and predictive factors of anterior hypopituitarism after ischemic stroke. 89
null 88
Glucose metabolism alterations in acromegaly 87
Delta opioid receptor involvement in endocrine pathophysiology 86
Dopamine receptor 2 activation reduces cells viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 85
Interrelationships between calcitonin gene-related peptide and sympathoadrenomedullary system: Effects of administration of epinephrine and norepinephrine in healthy man 84
Clinical value of different responses of serum thyroglobulin to recombinant human thyrotropin in the follow-up of patients with differentiated thyroid carcinoma 84
Functional hypothalamic and drug-induced amenorrhea: an overview 84
Cerebrovascular disease and GH-IGF-i axis function 84
Systemic illness 83
Occurrence of pituitary dysfunction following traumatic brain injury 83
Evaluation of hormonal function in a series of incidentally discovered adrenal masses 83
Protein Kinase C: A Putative New Target for the Control of Human Medullary Thyroid Carcinoma Cell Proliferation in Vitro 83
Multiple somatostatin receptor subtypes activation reduces cell viability in non-functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 83
EFFECTS OF SOMATOSTATIN ANALOG TREATMENT ON GLUCOSE METABOLISM IN ACROMEGALY 83
Post-stroke inflammatory response may influence pituitary function in patients with brain ischemic and hemorrhagic injury 83
Sindrome di McCune-Albright 82
Effect of delta-opioid receptor agonist deltorphin on circulating concentrations of luteinizing hormone and follicle stimulating hormone in healthy fertile women 80
ADRENAL INCIDENTALOMA: CLINICAL AND METABOLIC ASPECTS DURING LONG-TERM FOLLOW-UP 80
Sistema Simpatoadrenomidollare nei pazienti acromegalici 80
Role of Piuitary Tumour Transforming Gene 1 in medullary thyroid carcinoma 79
HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy 79
Fisiopatologia del sistema vasopressina 77
Inflammatory cytokines and neurotrophic factors correlate with pituitary function after stroke 76
Human galanin reduces plasma norepinephrine levels in man 75
Efficacy of tolvaptan treatment in a patient with syndrome of inappropriate antidiuresis (SIAD) after severe traumatic brain injury 75
Efficay and safety of everolimus in metastatic gastroenteropancreatic neuroendocrine tumors 75
FISIOPATOLOGIA, CLASSIFICAZIONE, PATOGENESI (ACROMEGALIA) 74
INVECCHIAMENTO E GH 74
A Novel PKC beta II Inhibitor Induces Antiproliferative Effects in Human Pancreatic Neuroendocrine Tumor Cells 74
IPOPITUITARISMO E TRAUMA CRANICO. 74
Atypical femoral fractures as a complication of long-term bisphosphonate therapy 73
ASSE GH-IGF-I NELL'INVECCHIAMENTO 73
Regression of liver metastases of occult carcinoid tumor with slow release Lanreotide therapy. 73
Dual-energy X-ray absorptiometry pitfalls in Thalassemia Major 73
Vecchi e nuovi analoghi della somatostatina e loro meccanismo d'azione 72
Pathogenesis and prevalence of hypertension in acromegaly 72
Prevalence of hyopituitarism in post-acute and chronic phase of hemorrhagic stroke 72
GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment. 71
PATOLOGIA CEREBRALE ACQUISITA ED IPOPITUITARISMO 71
Evidence for integrity of the growth hormone/insulin-like growth factor-1 axis in patients with severe head trauma during rehabilitation 71
Follow-up dei pazienti sottoposti a terapia chirurgica per adenomi ipofisari non secernenti. 71
Replacement therapy and quality of life improvement in adult GHD patients 71
ASYMPTOMATIC HYPERCALCITONINEMIA IN A PANCREATIC ENDOCRINE CARCINOMA ASSOCIATED WITH A PAPILLARY THYROID CANCER 71
Review of Cortina criteria for the diagnosis of acromegaly 70
Selective Cyclo-oxygenase 2 inhibitors revert chemoresistance In Medullary thyroid carcinoma by a mechanism mediated by P-gp and PGH2 69
Efficay and safety of teriparatide treatment 68
Role of GH-IGF-1 excess on periodontal tissues 68
IGF-I proliferative effects are inhibited by targeting PKC in human neuroendocrine tumor cells 68
A new VHL polymorphism in a big family from Ferrara 67
Sindrome di Von Hippel-Lindau 67
Targeting PKC in human pancreatic neuroendocrine tumor cells 66
Totale 9.348
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.663
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 7.154
Totale 60.817
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.524 0 0 0 277 115 249 129 210 117 261 135 31
2020/20211.368 147 104 58 169 63 147 37 162 31 185 198 67
2021/20221.387 36 139 90 60 55 58 48 61 42 120 118 560
2022/20231.527 155 136 52 203 207 230 74 114 214 16 69 57
2023/2024834 68 95 50 25 51 176 25 79 25 24 24 192
2024/2025442 99 76 267 0 0 0 0 0 0 0 0 0
Totale 11.689